Glucose transporters in the metabolic syndrome;Transportadores de glicose na síndrome metabólica

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 2, 2006, Pages 177-189

  Machado, Ubiratan Fabres ^a   Schaan, Beatriz D ^b   Seraphim, Patrícia M ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Glucose transporter; GLUT; GLUT4; Insulin resistance; Metabolic syndrome

Indexed keywords

GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4;

HUMAN; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; REVIEW;

DIABETES MELLITUS, TYPE 2; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GLUCOSE TRANSPORTER TYPE 2; GLUCOSE TRANSPORTER TYPE 4; HUMANS; METABOLIC SYNDROME X; OBESITY;

EID: 33744482309     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302006000200004     Document Type: Review

References (91)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
2. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448-54.
3. Pankow JS, Duncan BB, Schmidt MI, Ballantyne CM, Couper DJ, Hoogeveen RC, et al. Fasting plasma free fatty acids and risk of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes Care 2004;27:77-82.
4. Scheepers A, Joost HG, Schurmann A. The glucose transporter families SGLT and GLUT: Molecular basis of normal and aberrant function. J Parenter Enteral Nutr 2004;28(5):364-71.
5. Wu X, Freeze HH. GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. Genomics 2002;80:553-7.
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
7. Thorens B, Charron MJ, Lodish HF. Molecular physiology of glucose transporters. Diabetes Care 1990;13:209-18.
8. Rea S, James DE. Moving GLUT4: The biogenesis and trafficking of GLUT4 storage vesicles. Diabetes 1997;46:1667-77.
9. Folli F, Saad MJ, Velloso L, Hansen H, Carandente O, Feener EP, et al. Cross-talk between insulin and angiotensin II signalling systems. Exp Clin Endocrinol Diabetes 1999;107(2):133-9.
10. Kloting N, Bluher M, Kloting I. The polygenetically inherited metabolic syndrome of WOKW rats is associated with insulin resistance and altered gene expression in adipose tissue. Diabetes Metab Res Rev 2005;[Epub ahead of print].
11. Machado UF, Shimizu Y, Saito M. Decreased glucose transporter (GLUT 4) content in insulin-sensitive tissues of obese aurothioglucose- and monosodium glutamate-treated mice. Horm Metab Res 1993;25:462-5.
12. Machado UF, Shimizu I, Saito M. Reduced content and preserved translocation of glucose transporter (GLUT 4) in white adipose tissue of obese mice. Physiol Behav 1994;55:621-5.
13. Handberg A, Kayser L, Hoyer PE, Voldstedlund M, Hansen HP, Vinten J. Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats. Diabetologia 1993;36:481-6.
14. Lin JL, Asano T, Shibasaki Y, Tsukuda K, Katagiri H, Ishihara H, et al. Altered expression of glucose transporter isoforms with aging in rats - selective decrease in GluT4 in the fat tissue and skeletal muscle. Diabetologia 1991;34:477-82.
15. Gulve EA, Henriksen EJ, Rodnick KJ, Youn JH, Holloszy JO. Glucose transporters and glucose transport in skeletal muscles of 1- to 25-mo-old rats. Am J Physiol 1993;264(3Pt1):E319-27.
16. Houmard JA, Weidner MD, Dolan PL, Leggett-Frazier N, Gavigan KE, Hickey MS, et al. Skeletal muscle GLUT4 protein concentration and aging in humans. Diabetes 1995;44:555-60.
17. Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 1998;101:2377-86.
18. Shepherd PR, Kahn BB. Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N Engl J Med 1999;341:248-57.
19. Klip A, Tsakiridis T, Marette A, Ortiz PA. Regulation of expression of glucose transporters by glucose: A review of studies in vivo and in cell cultures. Faseb J 1994;8:43-53.
20. Seraphim PM, Assis TGR, Volpato CB, Nunes MT, Machado UF. GLUT4 gene expression insulin-resistant obese rats involves post-transcriptional poly-A tails mRNA modulation. Diab Res Clin Prac 2000;50:S157-8.
21. Papa PC, Seraphim PM, Machado UF. Loss of weight restores GLUT 4 content in insulin-sensitive tissues of monosodium glutamate-treated obese mice. Int J Obes Relat Metab Disord 1997;21:1065-70.
22. de Carvalho Papa P, Vargas AM, da Silva JL, Nunes MT, Machado UF. GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice. Life Sci 2002;71:1917-28.
23. Smith U. Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance - is insulin resistance initiated in the adipose tissue? Int J Obes Relat Metab Disord 2002;26:897-904.
24. Guerre-Millo M. Adipose tissue and adipokines: For better or worse. Diabetes Metab 2004;30:13-9.
25. Mora S, Pessin JE. An adipocentric view of signaling and intracellular trafficking. Diabetes Metab Res Rev 2002;18:345-56.
26. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994;94:1543-9.
27. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994;43:1271-8.
28. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001;409:729-33.
29. Tozzo E, Gnudi L, Kahn BB. Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology 1997;138:1604-11.
30. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 1993;268:22243-6.
31. Carvalho E, Kotani K, Peroni OD, Kahn BB. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab 2005;289:E551-61.
32. Zanquetta MM, Seraphim PM, Sumida DH, Cipolla-Neto J, Machado UF. Calorie restriction reduces pinealectomy-induced insulin resistance by improving GLUT4 gene expression and its translocation to the plasma membrane. J Pineal Res 2003;35:141-8.
33. Lima FB, Machado UF, Bartol I, Seraphim PM, Sumida DH, Moraes SM, et al. Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats. Am J Physiol 1998;275(6Pt1):E934-41.
34. Paternostro G, Clarke K, Heath J, Seymour AM, Radda GK. Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res 1995;30:205-11.
35. Campbell IW, Dominiczak AF, Livingstone C, Gould GW. Analysis of the glucose transporter compliment of metabolically important tissues from the Milan hypertensive rat. Biochem Biophys Res Commun 1995;211:780-91.
36. Chiappe De Cingolani GE, Caldiz CI. Insulin resistance and GLUT-4 glucose transporter in adipocytes from hypertensive rats. Metabolism 2004;53:382-7.
37. Katayama S, Inaba M, Maruno Y, Morita T, Awata T, Oka Y. Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: Enhanced gene expression and synthesis of skeletal muscle glucose transporter 4. Hypertens Res 1997;20:279-86.
38. Okamoto MM, Sumida DH, Carvalho CR, Vargas AM, Heimann JC, Schaan BD, et al. Changes in dietary sodium consumption modulate GLUT4 gene expression and early steps of insulin signaling. Am J Physiol Regul Integr Comp Physiol 2004;286:R779-85.
39. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998;49:235-61.
40. Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats. Metabolism 2001;50:1294-300.
41. Al-Khalili L, Forsgren M, Kannisto K, Zierath JR, Lonnqvist F, Krook A. Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma coactivator 1. Diabetologia 2005;48:1173-9.
42. da Costa Lima NK, Lima FB, dos Santos EA, Okamoto MM, Matsushita DH, Hell NS, et al. Chronic salt overload increases blood pressure and improves glucose metabolism without changing insulin sensitivity. Am J Hypertens 1997;10(7Pt1):720-7.
43. Prada P, Okamoto MM, Furukawa LN, Machado UF, Heimann JC, Dolnikoff MS. High- or low-salt diet from weaning to adulthood: Effect on insulin sensitivity in Wistar rats. Hypertension 2000;35(1Pt2):424-9.
44. Liu ML, Gibbs EM, McCoid SC, Milici AJ, Stukenbrok HA, McPherson RK, et al. Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control. Proc Natl Acad Sci USA 1993;90:11346-50.
45. Silva JL, Giannocco G, Furuya DT, Lima GA, Moraes PA, Nachef S, et al. NF-kappaB, MEF2A, MEF2D and HIF1-a involvement on insulin- and contraction-induced regulation of GLUT4 gene expression in soleus muscle. Mol Cell Endocrinol 2005;240(1-2):82-93.
46. Thorens B. Facilitated glucose transporters in epithelial cells. Annu Rev Physiol 1993;55:591-608.
47. Im SS, Kang SY, Kim SY, Kim HI, Kim JW, Kim KS, et al. Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes. Diabetes 2005;54:1684-91.
48. Powell EE, Jonsson JR, Clouston AD. Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease. Ann Intern Med 2005;143:753-4.
49. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005;143:722-8.
50. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004;279:32345-53.
51. Okamoto Y, Tanaka S, Haga Y. Enhanced GLUT2 gene expression in an oleic acid-induced in vitro fatty liver model. Hepatol Res 2002;23:138-44.
52. Tomie Furuya D, Binsack R, Onishi ME, Monteiro Seraphim P, Fabres Machado U. Low ethanol consumption induces enhancement of insulin sensitivity in liver of normal rats. Life Sci 2005;77:1813-24.
53. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
54. Reddy S, Young M, Poole CA, Ross JM. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: A comparative immunohistochemical study by light and confocal microscopy. Gen Comp Endocrinol 1998;111:9-19.
55. Picinato MC, Curi R, Machado UF, Carpinelli AR. Soybean-and olive-oils-enriched diets increase insulin secretion to glucose stimulus in isolated pancreatic rat islets. Physiol Behav 1998;65:289-94.
56. Kim HI, Kim JW, Kim SH, Cha JY, Kim KS, Ahn YH. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes 2000;49:1517-24.
57. Brosius 3rd FC, Nguyen N, Egert S, Lin Z, Deeb GM, Haas F, et al. Increased sarcolemmal glucose transporter abundance in myocardial ischemia. Am J Cardiol 1997;80(3A):77A-84A.
58. Simões MV, Egert S, Ziegler S, Miyagawa M, Reder S, Lehner T, et al. Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts. J Am Coll Cardiol 2004;43:1690-7.
59. Brosius 3rd FC, Liu Y, Nguyen N, Sun D, Bartlett J, Schwaiger M. Persistent myocardial ischemia increases GLUT1 glucose transporter expression in both ischemic and non-ischemic heart regions. J Mol Cell Cardiol 1997;29:1675-85.
60. Kraegen EW, Sowden JA, Halstead MB, Clark PW, Rodnick KJ, Chisholm DJ, et al. Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: Fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4. Biochem J 1993;295 (Pt1):287-93.
61. Luiken JJ, Coort SL, Koonen DP, Bonen A, Glatz JF. Signalling components involved in contraction-inducible substrate uptake into cardiac myocytes. Proc Nutr Soc 2004;63:251-8.
62. Russell 3rd RR, Bergeron R, Shulman GI, Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 1999;277(2Pt2):H643-9.
63. Egert S, Nguyen N, Brosius 3rd FC, Schwaiger M. Effects of wortmannin on insulin- and ischemia-induced stimulation of GLUT4 translocation and FDG uptake in perfused rat hearts. Cardiovasc Res 1997;35:283-93.
64. Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 2000;279:E1104-13.
65. Vettor R, Fabris R, Serra R, Lombardi AM, Tonello C, Granzotto M, et al. Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle. Int J Obes Relat Metab Disord 2002;26:838-47.
66. Morel S, Berthonneche C, Tanguy S, Toufektsian MC, Perret P, Ghezzi C, et al. Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats. Mol Cell Biochem 2005;272(1-2):9-17.
67. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE, et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004;93:40-4.
68. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: Sexrelated differences in the Framingham Heart Study. Circulation 2003;107:448-54.
69. Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 1995;377:151-5.
70. Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart. Diabetes 2002;51:1110-7.
71. Bahr M, Spelleken M, Bock M, von Holtey M, Kiehn R, Eckel J. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes. Diabetologia 1996;39:766-74.
72. Park JL, Loberg RD, Duquaine D, Zhang H, Deo BK, Ardanaz N, et al. GLUT4 facilitative glucose transporter specifically and differentially contributes to agonistinduced vascular reactivity in mouse aorta. Arterioscler Thromb Vasc Biol 2005;25:1596-602.
73. Atkins KB, Johns D, Watts S, Clinton Webb R, Brosius 3rd FC. Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension. J Hypertens 2001;19:1581-7.
74. Atkins KB, Northcott CA, Watts SW, Brosius FC. Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries. Am J Physiol Heart Circ Physiol 2005;288:H235-43.
75. Bergandi L, Silvagno F, Russo I, Riganti C, Anfossi G, Aldieri E, et al. Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003;23:2215-21.
76. Karam JH. Hypoglycemic disorders. In: Greenspan FS, Gardner DG, eds. Basic & clinical endocrinology. 5th edition. New York:Mc Graw-Hill; 2001. p.701.
77. Fernandes R, Suzuki K, Kumagai AK. Inner blood-retinal barrier GLUT1 in long-term diabetic rats: an immunogold electron microscopic study. Invest Ophthalmol Vis Sci 2003;44:3150-4.
78. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998;47:1953-9.
79. Gaudreault N, Scriven DR, Moore ED. Characterization of glucose transporters in the intact coronary artery endothelium in rats: GLUT-2 upregulated by long-term hyperglycaemia. Diabetologia 2004;47:2081-92.
80. Wright EM. Renal Na(+)-glucose cotransporters. Am J Physiol Renal Physiol 2001;280:F10-8.
81. Vestri S, Okamoto MM, de Freitas HS, Aparecida dos Santos R, Nunes MT, Morimatsu M, et al. Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat. J Membr Biol 2001;182:105-12.
82. Schaan BD, Irigoyen MC, Lacchini S, Moreira ED, Schmid H, Machado UF. Sympathetic modulation of the renal glucose transporter GLUT2 in diabetic rats. Auton Neurosci 2005;117:54-61.
83. Chin E, Zamah AM, Landau D, Gronbcek H, Flyvbjerg A, LeRoith D, et al. Changes in facilitative glucose transporter messenger ribonucleic acid levels in the diabetic rat kidney. Endocrinology 1997;138:1267-75.
84. Dominguez JH, Camp K, Maianu L, Garvey WT. Glucose transporters of rat proximal tubule: Differential expression and subcellular distribution. Am J Physiol 1992;262(5Pt2):F807-12.
85. Freitas HS, Schaan BD, Seraphim PM, Nunes MT, Machado UF. Acute and short-term insulin-induced molecular adaptations of GLUT2 gene expression in the renal cortex of diabetic rats. Mol Cell Endocrinol 2005;237(1-2):49-57.
86. D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats. Auton Neurosci 2003;104:88-94.
87. Zhang J, Liu Z, Liu D, Li L. Identification of glucose transporter-1 and its functional assay in mouse glomerular mesangial cells cultured in vitro. Chin Med Sci J 2001;16:35-9.
88. Li Y, Liu Z, Liu D, Zhang J, Chen Z, Li L. Identification and function of glucose transporter 1 in human mesangial cells. Chin Med J (Engl) 2001;114:824-8.
89. D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocininduced diabetic rats: Implications for the development of nephropathy complicating diabetes. Horm Metab Res 2001;33:664-9.
90. Schaan BD, Irigoyen MC, Bertoluci MC, Lima NG, Passaglia J, Hermes E, et al. Increased urinary TGF-beta1 and cortical renal GLUT1 and GLUT2 levels: Additive effects of hypertension and diabetes. Nephron Physiol 2005;100:43-50.
91. Huggett RJ, Burns J, Mackintosh AF, Mary DA. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004;44:847-52.